Amrish Narrandes, Head of Unlisted Equity Transactions at Futuregrowth explains that Impulse Biomedical is the…
Impulse AdminMay 29, 2021
Insights & Updates
Explore our progress on industry collaborations.
Impulse’s flagship device, the ZiBiPen, could revolutionise the emergency treatment of life-threatening anaphylaxis.
Impulse AdminMarch 21, 2021
A collaboration between biomedical engineers and a clinician at the University of Cape Town led…
Impulse AdminNovember 22, 2019
A team of South African biomedical engineers have built a cheap replacement for the EpiPen…
Impulse AdminMay 24, 2018
Journal Papers
Explore our research and publications.
We need to change the way we think about Africa, not as consumers of medical…
Impulse AdminDecember 16, 2019
